P

Penumbra Inc

Neurovascular and peripheral medical devices manufacturer

Senior SQL Administrator

Full-Time
$140k - $200k/yr+ Equity program
Senior, Expert
Bachelor's
Alameda, CA, USA
In Person
DevOps & InfrastructureDatabase Administration
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in Computer Science, Information Technology, Engineering, Data Management, or a related field, with 8+ years of enterprise-level database administration and/or database engineering experience, or an equivalent combination of education and experience.
  • At least 5 years of experience supporting high availability, disaster recovery, backup, restore, and database recovery strategies for business-critical systems.
  • Strong experience with SQL Server performance tuning, indexing, query optimization, execution plans, wait statistics, SQL Agent jobs, and database maintenance plans.
  • Experience administering SQL Server Always On Availability Groups, failover clustering, log shipping, replication, or equivalent high availability technologies.
  • Experience with database security practices, including least-privilege access, role-based permissions, encryption, auditing, service accounts, and privileged access controls.
  • Experience with PowerShell, T-SQL scripting, automation, monitoring, alerting, and operational reporting.
  • Experience with enterprise backup platforms, restore validation, database integrity checks, and disaster recovery testing.
  • Working knowledge of Windows Server, Active Directory, DNS, networking fundamentals, storage, virtualization, and cloud infrastructure as they relate to database services.
  • Ability to plan, organize, and document complex database administration activities and configure systems in alignment with institutional policies and procedures.
  • Ability to manage multiple priorities, handle concurrent projects, respond effectively to urgent or complex operational issues, and communicate clearly with technical and non-technical stakeholders.
  • High degree of accuracy, attention to detail, data stewardship, documentation discipline, and organizational skills.
  • Willingness and ability to work on site.
  • Ability to perform the stated physical and office tasks, including lifting and moving up to 10 pounds, moving between buildings and floors, remaining stationary and using office equipment for extended periods, reading and preparing emails and documents and spreadsheets, accessing supplies or file cabinets, and communicating and exchanging accurate information with employees at all levels.
Responsibilities
  • Manage day-to-day operations of enterprise database platforms, including configuration, maintenance, patching, backups, restores, performance, security, and capacity.
  • Administer, maintain, and optimize Microsoft SQL Server environments across on-premises, virtualized, and cloud-hosted platforms.
  • Monitor database health, performance, job execution, storage utilization, blocking, deadlocks, replication, availability groups, and backup success.
  • Perform database performance tuning, including query analysis, indexing strategy, execution plan review, statistics maintenance, wait analysis, and resource optimization.
  • Implement and support high availability and disaster recovery solutions, including SQL Server Always On Availability Groups, clustering, log shipping, replication, backups, and restore testing.
  • Plan and execute database maintenance activities, including index maintenance, integrity checks, patching, upgrades, and lifecycle management.
  • Support database capacity planning, storage forecasting, performance baselining, and scalability planning for business-critical systems.
  • Provide after-hours on-call support on a rotation schedule with other staff members.
  • Maintain database security controls, including authentication, authorization, least-privilege access, role-based permissions, encryption, auditing, and privileged access review.
  • Partner with Security and Infrastructure teams to support secure database connectivity, certificate use, service accounts, firewall rules, vulnerability remediation, and patch compliance.
  • Protect enterprise data integrity through routine DBCC checks, backup validation, restore testing, change review, and controlled release practices.
  • Review and support database changes, schema updates, stored procedures, SQL Agent jobs, integrations, and application releases to reduce operational risk.
  • Maintain database inventory, configuration standards, operational documentation, recovery procedures, and support runbooks.
  • Lead troubleshooting and root-cause analysis for complex database incidents, performance degradation, failed jobs, restore issues, connectivity problems, and application-impacting database events.
  • Develop and maintain automation for database maintenance, monitoring, alerting, reporting, backup validation, user access review, and operational support activities.
  • Create tools, dashboards, procedures, and documentation to support IT, Applications Development, Client Support, Quality, and business teams.
  • Recommend database design, configuration, indexing, monitoring, security, and resiliency improvements to strengthen performance, reliability, security, and scalability.
  • Stay current with developments in database administration, SQL Server, Azure SQL, backup and recovery practices, automation, security, and enterprise compliance technologies.
  • Follow established change management, release management, incident management, security, and governance practices for database platforms.
  • Adhere to the Company's Quality Management System (QMS) and domestic and global quality system regulations, standards, and procedures.
  • Understand and adhere to applicable security, privacy, and compliance principles, regulations, standards, and procedures.
  • Ensure other department members follow the Quality Management System, regulations, standards, and procedures.
  • Ensure database administration activities are documented, controlled, auditable, and aligned with applicable IT and quality system requirements.
  • Collaborate with IT, application owners, business partners, vendors, and support teams to maintain reliable database operations and resolve issues effectively.
  • Communicate technical and complex database information clearly, both verbally and in writing.
  • Perform other work-related duties as assigned.
Desired Qualifications
  • Experience supporting Azure SQL Database, Azure SQL Managed Instance, or SQL Server hosted in Microsoft Azure.
  • Experience supporting integrations with ERP, MES, LIMS, QMS, reporting, data warehouse, or enterprise application platforms.
  • Experience with SQL Server Integration Services (SSIS), SQL Server Reporting Services (SSRS), Power BI gateways, or related reporting and integration technologies.
  • Microsoft SQL Server, Azure Database Administrator Associate, or equivalent database certification.

About the company

Penumbra develops and sells medical devices for neurovascular and peripheral vascular conditions. Its products assist doctors in treating stroke and other vascular diseases by delivering—through systems like the Penumbra System and Indigo System—catheters, coils, and evacuation devices that are placed inside blood vessels. The company differentiates itself with a broad, integrated portfolio and a global sales network across Europe and the Americas, emphasizing engineering and clinical performance. Its goal is to improve patient outcomes and sustain growth by investing in ongoing research and development to expand its capabilities.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Alameda, California

Founded

2004

Get referred to Penumbra Inc

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $390.0 million, up 14.9%, with 67.9% gross margin.
  • September 9, 2026 Link launch expands Lightning Bolt workflows for resistant clot.
  • Magnendo's $18 million round, led by Penumbra, extends its stroke robotics ecosystem.

What critics are saying

  • June 3, 2026 RED 68 recall flags manufacturing defects and franchise reliability.
  • Incuvate sued Penumbra on August 19, 2026 over THUNDERBOLT patents; injunction risk.
  • Boston Scientific's acquisition still requires approvals; any 2026 slip derails employee retention and valuation.

What makes Penumbra Inc unique

  • Penumbra's CAVT platform pairs computer control with thrombectomy; THUNDERBOLT cleared FDA in 2026.
  • Broad neurovascular and peripheral portfolios sell into over 100 countries.
  • Deep physician evidence engine adds leaders like Donald Frei and published stroke studies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Business Insider
Oct 2nd, 2026
RBC Capital keeps their Hold rating on Penumbra (PEN).

RBC Capital keeps their Hold rating on Penumbra (PEN). Oct. 2, 2026, 09:47 PM In a report released on October 1, Kendall Au from RBC Capital maintained a Hold rating on Penumbra, with a price target of $374.00. The company's shares closed yesterday at $318.00. According to TipRanks, Au is an analyst with an average return of -3.6% and a 22.22% success rate. Au covers the Healthcare sector, focusing on stocks such as Becton Dickinson, GE Healthcare Technologies Inc, and Boston Scientific. Penumbra has an analyst consensus of Hold, with a price target consensus of $358.40. Based on Penumbra's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $390.05 million and a net profit of $34.81 million. In comparison, last year the company earned a revenue of $339.46 million and had a net profit of $45.27 million Read More on PEN:

Penumbra, Inc.
Sep 9th, 2026
Penumbra launches Link, expanding vascular thrombectomy options for physicians.

Penumbra launches Link, expanding vascular thrombectomy options for physicians. September 9, 2026 Penumbra recently launched the Link(TM) clot capture device designed to support the removal of arterial thrombus when used in conjunction with Lightning Bolt(R) technology. Link is designed to lock and hold clot, connecting to the power of computer assisted vacuum thrombectomy (CAVT(R) to secure and maximize clot extraction. "Link expands the toolkit available to physicians by providing an additional mechanical clot engagement option that can help address resistant thrombus while maintaining aspiration with CAVT," said James F. Benenati, MD, FSIR, chief medical officer at Penumbra. "By offering clinicians greater flexibility in challenging cases, it has the potential to improve procedural efficiency and support more effective patient care." Deployed into thrombus, Link engages and mobilizes organized clot while aspiration facilitates clot ingestion into the aspiration catheter. Designed to complement existing Lightning Bolt workflows, Link can be incorporated when additional mechanical clot engagement is desired, without requiring a fundamentally different procedural approach. Early physician experience has highlighted Link's ability to work synergistically with Lightning Bolt technology. "Link appeared to provide a secure hold on the embolus, allowing Bolt to more effectively aspirate the residual thrombus," said Thomas Heafner, MD, after using Link with Bolt 7. "Combining Link with Lightning Bolt resulted in rapid and effective clot clearance." "Link represents an important advancement in our CAVT portfolio, providing an additional option for engaging and removing challenging blood clots," said Shruthi Narayan, president of Penumbra. "Link was designed to bring a new dimension to thrombectomy by combining secure clot engagement with the power of modulated aspiration, offering clinicians an additional therapeutic option for some of the most challenging cases. This launch reflects our continued commitment to developing technologies that advance vascular care and improve patient outcomes." Designed to Secure Clot and Maximize Extraction LINK is designed to lock and hold clot while leveraging the power of CAVT to support clot removal. Its unique architecture is engineered to minimize vessel wall engagement and support atraumatic clot extraction. Important Safety Information Additional information about Penumbra's products can be located on Penumbra's website at https://www.penumbrainc.com/products/peripheral-thrombectomy-cavt/. The clinical results presented herein are for informational purposes only and may not be predictive for all patients. Individual results may vary depending on patient-specific attributes and other factors. Caution: Federal (USA) law restrictions these devices to sale by or on the order of a physician. Prior to use, please refer to the Instructions for Use (IFU) for complete product indications, contraindications, warnings, precautions, potential adverse events, and detailed instructions for use. For the complete Penumbra IFU Risk Summary Statements, visit: peninc.info/risk. Please contact your local Penumbra representative for more information.

GlobeNewswire
Aug 25th, 2026
Incuvate files patent infringement lawsuit against Penumbra.

Incuvate files patent infringement lawsuit against Penumbra. Complaint alleges Penumbra's THUNDERBOLT(TM) system infringes five Incuvate patents covering blood-clot detection technology. August 25, 2026 15:28 ET | Source: Incuvate LLC IRVINE, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) - Incuvate, LLC today announced that it has filed a patent-infringement lawsuit against Penumbra, Inc. in the U.S. District Court for the Northern District of California. The lawsuit, filed August 19, 2026, alleges that Penumbra's recently launched THUNDERBOLT(TM) Neurovascular Thrombectomy System and related components infringe five Incuvate patents directed to real-time aspiration monitoring technology used in catheter-based thrombectomy procedures. Incuvate's patents cover technology that uses pressure sensors, microprocessors, and pre-set pressure thresholds or differentials to provide real-time visual and audible feedback during aspiration procedures. Incuvate alleges that this technology helps distinguish between clot engagement and blood flow and provides clinicians with valuable information during thrombectomy procedures. The complaint identifies Penumbra's THUNDERBOLT system, Penumbra ENGINE vacuum source, THUNDERBOLT tubing and module, and associated RED Reperfusion Catheters as accused products. Incuvate alleges that these products use patented technology to detect flow conditions, including the presence of clot, and provide users with feedback regarding flow status. Through this lawsuit, Incuvate seeks to hold Penumbra accountable for what Incuvate alleges is Penumbra's unauthorized and willful infringement of the technologies embodied in the asserted patents. Incuvate is seeking damages, injunctive relief, and other remedies described in the complaint. A copy of the complaint is available through PACER Monitor in Incuvate, LLC v. Penumbra, Inc., Case No. 4:26-cv-08658. About Incuvate Incuvate works with medical device entrepreneurs to develop early-stage concepts into innovative products and leads them to market via new companies it finances, builds, and manages. Learn more at incuvatellc.com Media Contact Lance Capel Director of Strategy & External Relations [email protected]

Penumbra, Inc.
Aug 10th, 2026
Dr. Donald Frei joins Penumbra as Associate Chief Medical Officer of Neuro.

Dr. Donald Frei joins Penumbra as Associate Chief Medical Officer of Neuro. August 10, 2026 Penumbra announced today that Donald Frei, MD, FSNIS, FACR, will serve as Associate Chief Medical Officer of Neuro. A nationally recognized neurointerventional surgeon, Dr. Frei brings clinical and research expertise in stroke and neurovascular care to Penumbra's clinical leadership team. Reporting to James Benenati, MD, FSIR, Chief Medical Officer of Penumbra, Dr. Frei will help guide Penumbra's neurovascular clinical strategy, support evidence development, and collaborate with physicians worldwide to advance patient care. "Dr. Frei has dedicated his career to advancing neurovascular care, from pioneering faster stroke recanalization protocols to helping establish the clinical evidence behind therapies that improve patient outcomes," said Dr. Benenati. "His deep clinical expertise, commitment to innovation, and passion for patient care will be invaluable as we continue to expand the impact of our neurovascular technologies around the world." Throughout his career, Dr. Frei has authored more than 200 peer-reviewed publications and contributed to the advancement of neurovascular therapies through extensive clinical research and evidence generation. Recently, Dr. Frei was the co-principal investigator of the THUNDER Study, which demonstrated that Penumbra's CAVT(TM)(Computer Assisted Vacuum Thrombectomy) platform with THUNDERBOLT technology is safe and effective, paving the way for FDA clearance and CE Mark. Dr. Frei was also instrumental in launching the Get Ahead of Stroke(R) campaign to improve stroke triage and expand access to life-saving neuroendovascular care. "With the recent launch of CAVT with THUNDERBOLT, the neurovascular space is prime for transformation," said Dr. Frei. "I look forward to this opportunity to help advance innovation, generate evidence, deepen trust and closer collaboration with our medical and professional societies, and improve access to care so more patients are able to benefit from the latest technology." Dr. Frei is a leading board-certified neurointerventional surgeon and is a past president of the Society of NeuroInterventional Surgery. He earned his medical degree from the University of Cincinnati College of Medicine and completed his residency training in diagnostic radiology at Tulane University Medical Center. He subsequently completed fellowship training in neuroradiology and endovascular surgical neuroradiology at Washington University's Mallinckrodt Institute of Radiology. He has been recognized as a Fellow of the Society of NeuroInterventional Surgery (FSNIS) and a Fellow of the American College of Radiology (FACR).

Yahoo Finance
Jul 30th, 2026
Penumbra reports $390M Q2 revenue, up 14.9% ahead of Boston Scientific acquisition

Penumbra reported second quarter 2026 revenue of $390.0 million, up 14.9% year-over-year. The thrombectomy company's global thrombectomy revenue reached $259.0 million, increasing 12.5%, whilst embolization and access revenue grew 20.0% to $131.1 million. Gross profit margin improved to 67.9%, up 1.9 percentage points from the prior year. Operating income was $41.0 million, with net income of $34.8 million. Total operating expenses stood at $223.9 million, including $6.9 million in acquisition-related costs. Due to Boston Scientific's pending acquisition of Penumbra, the company will not provide full-year 2026 guidance or host a conference call to discuss results. Penumbra operates in over 100 countries, focusing on thrombectomy technologies for conditions including ischaemic stroke and pulmonary embolism.